Aaron M. Conger , Dustin J. Randall , Beau P. Sperry , Keith T. Kuo , Russell Petersen , A. Michael Henrie , Richard W. Kendall , Erica F. Bisson , Masaru Teramoto , Brook I. Martin , Taylor R. Burnham , Zachary L. McCormick
{"title":"颈椎经椎间孔硬膜外类固醇注射治疗颈椎根性疼痛的有效性:报告 12 个月疗效的前瞻性队列研究","authors":"Aaron M. Conger , Dustin J. Randall , Beau P. Sperry , Keith T. Kuo , Russell Petersen , A. Michael Henrie , Richard W. Kendall , Erica F. Bisson , Masaru Teramoto , Brook I. Martin , Taylor R. Burnham , Zachary L. McCormick","doi":"10.1016/j.inpm.2023.100379","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the effectiveness of cervical transforaminal epidural steroid injection (CTFESI) for the treatment of unilateral cervical radicular pain.</p></div><div><h3>Design</h3><p>Single-group prospective cohort study.</p></div><div><h3>Methods</h3><p>Outcomes included ≥50% reductions in Numeric Rating Scale (NRS) for arm pain, ≥30% Neck Disability Index (NDI-5) improvement, health-related quality of life (EQ-5D), global improvement (PGIC), personal goal achievement (COMBI), Chronic Pain Sleep Index (CPSI), and healthcare utilization at one, three, six, and 12 months. Data analysis included descriptive statistics with the calculations of 95% confidence intervals (CIs), contingency table analysis, and multilevel logistic regression (LR) analysis, including a worst-case (WC) sensitivity analysis in which missing data were treated as treatment failure. Participants who were treated surgically were considered failures in the categorical analyses.</p></div><div><h3>Results</h3><p>33 consecutively enrolled participants (63.6% females, 51.2 ± 12.2 years of age, BMI 28.3 ± 4.5 kg/m<sup>2</sup>) were analyzed. Success rates for ≥50% reduction in NRS for arm pain at one, three, six and 12 months were 57.6% (95% CI 40.8–72.8%), 71.9% (95% CI 54.6–84.4%), 64.5% (95% CI 46.9–78.9%), and 64.5% (95% CI 46.9–78.9%). Success rates for ≥30% improvement in NDI-5 were 60.6% (95% CI 43.7–75.3%), 68.8% (95% CI 51.4–82.0%), 61.3% (95% CI 43.8–76.3%), and 71.0% (95% CI 53.4–83.9%). In WC analysis, success rates for ≥50% arm NRS and NDI-5 were 0–4.3% lower between 1 and 12 months. PGIC scores were at least “much improved” or “very much improved,” in 48.4–65.6% of participants between 1 and 12 months. 6.1%, 6.1%, and 3.0% had one, two, or three repeat injections, respectively. 18.2% of participants underwent surgery by 12 months. Participants showed significant improvements in arm NRS and NDI-5 after treatment (<em>p</em> < 0.05), multilevel logistic regression models showed no significant decline in improvements across the follow-up time points (<em>p</em> > 0.05).</p></div><div><h3>Conclusion</h3><p>Statistically significant and clinically meaningful improvements in pain and disability were observed after CTFESI for up to 12 months in individuals with unilateral cervical radicular pain.</p></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"3 1","pages":"Article 100379"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277259442300211X/pdfft?md5=35eb8dcd51f3e61be847444ec311a931&pid=1-s2.0-S277259442300211X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The effectiveness of cervical transforaminal epidural steroid injections for the treatment of cervical radicular pain: A prospective cohort study reporting 12-month outcomes\",\"authors\":\"Aaron M. Conger , Dustin J. Randall , Beau P. Sperry , Keith T. Kuo , Russell Petersen , A. Michael Henrie , Richard W. Kendall , Erica F. Bisson , Masaru Teramoto , Brook I. Martin , Taylor R. Burnham , Zachary L. McCormick\",\"doi\":\"10.1016/j.inpm.2023.100379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>To evaluate the effectiveness of cervical transforaminal epidural steroid injection (CTFESI) for the treatment of unilateral cervical radicular pain.</p></div><div><h3>Design</h3><p>Single-group prospective cohort study.</p></div><div><h3>Methods</h3><p>Outcomes included ≥50% reductions in Numeric Rating Scale (NRS) for arm pain, ≥30% Neck Disability Index (NDI-5) improvement, health-related quality of life (EQ-5D), global improvement (PGIC), personal goal achievement (COMBI), Chronic Pain Sleep Index (CPSI), and healthcare utilization at one, three, six, and 12 months. Data analysis included descriptive statistics with the calculations of 95% confidence intervals (CIs), contingency table analysis, and multilevel logistic regression (LR) analysis, including a worst-case (WC) sensitivity analysis in which missing data were treated as treatment failure. Participants who were treated surgically were considered failures in the categorical analyses.</p></div><div><h3>Results</h3><p>33 consecutively enrolled participants (63.6% females, 51.2 ± 12.2 years of age, BMI 28.3 ± 4.5 kg/m<sup>2</sup>) were analyzed. Success rates for ≥50% reduction in NRS for arm pain at one, three, six and 12 months were 57.6% (95% CI 40.8–72.8%), 71.9% (95% CI 54.6–84.4%), 64.5% (95% CI 46.9–78.9%), and 64.5% (95% CI 46.9–78.9%). Success rates for ≥30% improvement in NDI-5 were 60.6% (95% CI 43.7–75.3%), 68.8% (95% CI 51.4–82.0%), 61.3% (95% CI 43.8–76.3%), and 71.0% (95% CI 53.4–83.9%). In WC analysis, success rates for ≥50% arm NRS and NDI-5 were 0–4.3% lower between 1 and 12 months. PGIC scores were at least “much improved” or “very much improved,” in 48.4–65.6% of participants between 1 and 12 months. 6.1%, 6.1%, and 3.0% had one, two, or three repeat injections, respectively. 18.2% of participants underwent surgery by 12 months. Participants showed significant improvements in arm NRS and NDI-5 after treatment (<em>p</em> < 0.05), multilevel logistic regression models showed no significant decline in improvements across the follow-up time points (<em>p</em> > 0.05).</p></div><div><h3>Conclusion</h3><p>Statistically significant and clinically meaningful improvements in pain and disability were observed after CTFESI for up to 12 months in individuals with unilateral cervical radicular pain.</p></div>\",\"PeriodicalId\":100727,\"journal\":{\"name\":\"Interventional Pain Medicine\",\"volume\":\"3 1\",\"pages\":\"Article 100379\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S277259442300211X/pdfft?md5=35eb8dcd51f3e61be847444ec311a931&pid=1-s2.0-S277259442300211X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventional Pain Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S277259442300211X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Pain Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S277259442300211X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的评估颈椎经椎间孔硬膜外类固醇注射(CTFESI)治疗单侧颈椎根性疼痛的有效性。方法研究结果包括1、3、6和12个月时手臂疼痛的数字评分量表(NRS)降低≥50%、颈部残疾指数(NDI-5)改善≥30%、健康相关生活质量(EQ-5D)、整体改善(PGIC)、个人目标实现(COMBI)、慢性疼痛睡眠指数(CPSI)和医疗保健利用率。数据分析包括带有 95% 置信区间 (CI) 计算的描述性统计、或然率表分析和多层次逻辑回归 (LR) 分析,包括最坏情况 (WC) 敏感性分析,其中缺失数据被视为治疗失败。在分类分析中,接受手术治疗的参与者被视为失败者。结果分析了33名连续注册的参与者(63.6%为女性,51.2±12.2岁,BMI 28.3±4.5 kg/m2)。1个月、3个月、6个月和12个月时手臂疼痛NRS评分降低≥50%的成功率分别为57.6%(95% CI 40.8-72.8%)、71.9%(95% CI 54.6-84.4%)、64.5%(95% CI 46.9-78.9%)和64.5%(95% CI 46.9-78.9%)。NDI-5改善≥30%的成功率分别为60.6%(95% CI 43.7-75.3%)、68.8%(95% CI 51.4-82.0%)、61.3%(95% CI 43.8-76.3%)和71.0%(95% CI 53.4-83.9%)。在 WC 分析中,≥50% 臂 NRS 和 NDI-5 的成功率在 1 个月和 12 个月之间降低了 0-4.3%。在 1 至 12 个月期间,48.4-65.6% 的参与者的 PGIC 评分至少 "改善很多 "或 "改善很大"。分别有 6.1%、6.1% 和 3.0% 的参与者进行了一次、两次或三次重复注射。18.2%的参与者在 12 个月内接受了手术。治疗后,参与者的手臂 NRS 和 NDI-5 均有明显改善(p <0.05),多层次逻辑回归模型显示,随访时间点的改善程度没有明显下降(p >0.05)。结论在长达 12 个月的 CTFESI 治疗后,单侧颈椎根性疼痛患者的疼痛和残疾情况有明显改善,且具有临床意义。
The effectiveness of cervical transforaminal epidural steroid injections for the treatment of cervical radicular pain: A prospective cohort study reporting 12-month outcomes
Objectives
To evaluate the effectiveness of cervical transforaminal epidural steroid injection (CTFESI) for the treatment of unilateral cervical radicular pain.
Design
Single-group prospective cohort study.
Methods
Outcomes included ≥50% reductions in Numeric Rating Scale (NRS) for arm pain, ≥30% Neck Disability Index (NDI-5) improvement, health-related quality of life (EQ-5D), global improvement (PGIC), personal goal achievement (COMBI), Chronic Pain Sleep Index (CPSI), and healthcare utilization at one, three, six, and 12 months. Data analysis included descriptive statistics with the calculations of 95% confidence intervals (CIs), contingency table analysis, and multilevel logistic regression (LR) analysis, including a worst-case (WC) sensitivity analysis in which missing data were treated as treatment failure. Participants who were treated surgically were considered failures in the categorical analyses.
Results
33 consecutively enrolled participants (63.6% females, 51.2 ± 12.2 years of age, BMI 28.3 ± 4.5 kg/m2) were analyzed. Success rates for ≥50% reduction in NRS for arm pain at one, three, six and 12 months were 57.6% (95% CI 40.8–72.8%), 71.9% (95% CI 54.6–84.4%), 64.5% (95% CI 46.9–78.9%), and 64.5% (95% CI 46.9–78.9%). Success rates for ≥30% improvement in NDI-5 were 60.6% (95% CI 43.7–75.3%), 68.8% (95% CI 51.4–82.0%), 61.3% (95% CI 43.8–76.3%), and 71.0% (95% CI 53.4–83.9%). In WC analysis, success rates for ≥50% arm NRS and NDI-5 were 0–4.3% lower between 1 and 12 months. PGIC scores were at least “much improved” or “very much improved,” in 48.4–65.6% of participants between 1 and 12 months. 6.1%, 6.1%, and 3.0% had one, two, or three repeat injections, respectively. 18.2% of participants underwent surgery by 12 months. Participants showed significant improvements in arm NRS and NDI-5 after treatment (p < 0.05), multilevel logistic regression models showed no significant decline in improvements across the follow-up time points (p > 0.05).
Conclusion
Statistically significant and clinically meaningful improvements in pain and disability were observed after CTFESI for up to 12 months in individuals with unilateral cervical radicular pain.